跳至主要内容
临床试验/NCT02763514
NCT02763514已完成不适用

Efficacy Evaluation of 26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Cognitive Function and Mood in Healthy Adults

Northumbria University1 个研究点 分布在 1 个国家目标入组 337 人开始时间: 2016年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
337
试验地点
1
主要终点
Episodic memory

研究概览

简要总结

The purpose of this study is to investigate the effects of EPA- and DHA-enriched omega-3 polyunsaturated fatty acid dietary supplements on cognitive function (episodic memory, attention, working memory, executive function), subjective mood, alertness and mental fatigue after 26 weeks daily supplementation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
25 Years 至 49 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Aged 25 to 49 years inclusive
  • •Males and females
  • •Self-report of good health

排除标准

  • •English is not first language (some of the cognitive tasks have only been validated in native English speakers)
  • •Habitual consumption of oily fish exceeds one fish meal per week
  • •Habitual consumption of omega-3 dietary supplements in the previous 6 months
  • •Habitual use of dietary supplements within the last month (defined as more than 3 consecutive days or 4 days in total; some supplements that do not impact upon cognitive function e.g. garlic, protein, calcium are allowed. Please check with the research team if you are unsure)
  • •Are a smoker or consume any nicotine replacement products (e.g. chewing gum, e-cigarettes)
  • •Food allergies or sensitivities to any of the ingredients contained in the investigational product or any other foodstuff
  • •Pregnant, trying to get pregnant or breast feeding
  • •Body Mass Index outside of the range 18-35 kg/m2
  • •High blood pressure (systolic over 159 mm Hg or diastolic over 99 mm Hg)
  • •Currently taking blood pressure medication
  • •Currently taking blood thinning medication (e.g. aspirin, warfarin, heparin)
  • •Have a respiratory disorder that requires regular medication (Note: participants with asthma who only take their medication occasionally/as required are eligible for this study)
  • •Have frequent migraines that require medication (more than or equal to 1 per month)
  • •History or current diagnosis of drug/alcohol abuse
  • •History of kidney or liver disease, or other severe diseases of the gastrointestinal tract (e.g. iron accumulation, iron utilization disorders, hypercalcaemia, hypercalcaemia), that are likely to interfere with metabolism/absorption/secretion of the product under investigation
  • •History of neurological or psychiatric illness (excluding depressive illness and anxiety)
  • •History of head trauma
  • •Sleep disturbances and/or are taking sleep aid medication
  • •Blood disorders (e.g. anaemia, haemophilia, thrombocytosis)
  • •Diagnosis of type I or type II diabetes
  • •Heart disorder, or vascular illness
  • •Current diagnosis of depression and/or anxiety
  • •Over- or under-active thyroid
  • •Chronic gastrointestinal problems (e.g. Inflammatory Bowel Disease, Irritable Bowel Syndrome, celiac disease)
  • •Any known active infections
  • •Diagnosed with or may be at risk of having syphilis, hepatitis, the Human T - lymphotropic virus or the Human Immunodeficiency Virus
  • •Current or past breast cancer diagnosis and/or a mastectomy
  • •Health condition that would prevent fulfilment of the study requirements
  • •Currently participating in or in the past 4 weeks participated in other clinical or nutrition intervention studies

研究组 & 干预措施

DHA-enriched oil

Active Comparator

3 g PronovaPure 150:500 EE EU

干预措施: 3 g PronovaPure 150:500 EE EU (Dietary Supplement)

EPA-enriched oil

Active Comparator

3 g PronovaPure 500:200 EE EU

干预措施: 3 g PronovaPure 500:200 EE EU (Dietary Supplement)

Placebo

Placebo Comparator

3 g Olive oil

干预措施: 3 g Placebo (Dietary Supplement)

结局指标

主要结局

Episodic memory

时间窗: 26 weeks

An overall score for Episodic memory will be derived by calculating the average score from 6 separate standardised task outcomes (Zimmediate word recall accuracy + Zdelayed word recall accuracy + Zword recognition accuracy + Zpicture recognition accuracy - Zimmediate word recall errors - Zdelayed word recall errors)/6

Subjective fatigue

时间窗: 26 weeks

Subjective fatigue will be derived from the Fatigue subscale of the Profile of Mood States questionnaire

次要结局

  • Numeric Working memory(26 weeks)
  • Stroop task(26 weeks)
  • Rapid visual information processing(26 weeks)
  • Subjective alertness(26 weeks)
  • Subjective mental fatigue(26 weeks)
  • Simple reaction time(26 weeks)
  • Subjective confusion(26 weeks)
  • Subjective overall mood disturbance(26 weeks)
  • Verbal fluency(26 weeks)
  • Subjective vigour(26 weeks)
  • Subjective anger(26 weeks)
  • Subjective tension(26 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Philippa Jackson

Dr

Northumbria University

研究点 (1)

Loading locations...

相似试验

The Effects of DHA- and EPA-enriched Oils on... | 临床试验